$7.01
0.111.59%
At Close: -
$7.01
00.00%
After Hours: Jul 5, 4:01 PM EDT
15 minutes delayed
Aura Biosciences
AURANASDAQ
Aura Biosciences (NASDAQ:AURA) Stock, Analyst Ratings, Price Targets, Forecasts
Aura Biosciences Inc has a consensus price target of $23 based on the ratings of 10 analysis. The 3 most-recent analyst ratings were released by BTIG, JMP Securities, and Scotiabank on December 8, 2023, November 10, 2023, and July 27, 2023, respectively. With an average price target of $21 between BTIG, JMP Securities, and Scotiabank, there's an implied 199.57% upside for Aura Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BTIG
JMP Securities
Scotiabank
Evercore ISI Group
Cowen & Co.
1calculated from analyst ratings
Analyst Ratings for Aura Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 12/08/2023 | Buy Now | 199.57% | BTIG | Robert Hazlett | $38 → $21 | Maintains | Buy | Get Alert |
| 11/10/2023 | Buy Now | 171.04% | JMP Securities | Jonathan Wolleben | $21 → $19 | Maintains | Market Outperform | Get Alert |
| 07/27/2023 | Buy Now | 228.1% | Scotiabank | George Farmer | → $23 | Initiates | → Sector Outperform | Get Alert |
| 03/16/2023 | Buy Now | 256.63% | JMP Securities | Jonathan Wolleben | $30 → $25 | Maintains | Outperform | Get Alert |
| 11/11/2022 | Buy Now | 327.96% | JMP Securities | Jonathan Wolleben | $26 → $30 | Maintains | Market Outperform | Get Alert |
| 07/19/2022 | Buy Now | 270.9% | JMP Securities | Jonathan Wolleben | → $26 | Initiates | → Market Outperform | Get Alert |
| 11/23/2021 | Buy Now | 442.08% | BTIG | Robert Hazlett | — | Initiates | → Buy | Get Alert |
| 11/23/2021 | Buy Now | 399.29% | Evercore ISI Group | Liisa Bayko | — | Initiates | → Outperform | Get Alert |
| 11/23/2021 | Buy Now | — | Cowen & Co. | Phil Nadeau | — | Initiates | → Outperform | Get Alert |
| 11/23/2021 | Buy Now | 470.61% | SVB Leerink | Andrew Berens | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Aura Biosciences (AURA) stock?
The latest price target for Aura Biosciences (NASDAQ:AURA) was reported by BTIG on December 8, 2023. The analyst firm set a price target for $21.00 expecting AURA to rise to within 12 months (a possible 199.57% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aura Biosciences (AURA)?
The latest analyst rating for Aura Biosciences (NASDAQ:AURA) was provided by BTIG, and Aura Biosciences maintained their buy rating.
When was the last upgrade for Aura Biosciences (AURA)?
There is no last upgrade for Aura Biosciences
When was the last downgrade for Aura Biosciences (AURA)?
There is no last downgrade for Aura Biosciences.
When is the next analyst rating going to be posted or updated for Aura Biosciences (AURA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aura Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aura Biosciences was filed on December 8, 2023 so you should expect the next rating to be made available sometime around December 8, 2024.
Is the Analyst Rating Aura Biosciences (AURA) correct?
While ratings are subjective and will change, the latest Aura Biosciences (AURA) rating was a maintained with a price target of $38.00 to $21.00. The current price Aura Biosciences (AURA) is trading at is $7.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.